2m 2m 2m 2m 2m 2m 2m
Phibro Animal-A (PAHC)
NASDAQ
$35.60-$0.02 (-0.07%)
Price as of Sep 11, 2026 7:42 PM EDT- $772.0MMarket Cap
- -8.98%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Phibro Animal-A (PAHC)
$35.60-$0.02 (-0.07%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.5B +17.12% | 1.3B +27.37% | 1.0B +4.07% | 977.9M +3.78% | |
Cost of Revenue | 1.0B +12.20% | 896.3M +27.21% | 704.6M +3.67% | 679.7M +3.47% | |
Gross Profit | 512.5M +28.15% | 399.9M +27.74% | 313.1M +4.98% | 298.2M +4.50% | |
Sales and Marketing Expense | 318.1M +9.89% | 289.5M +11.43% | 259.8M +14.75% | 226.4M +9.68% | |
Research and Development Expense | -24.6M +3.48% | -23.7M -18.73% | -29.2M +19.67% | -24.4M +17.10% | |
Depreciation and Amortization Expense | 51.5M +12.96% | 45.6M +26.06% | 36.2M +6.37% | 34.0M +4.00% | |
Total Operating Expenses | 1.0B +12.20% | 896.3M +27.21% | 704.6M +3.67% | 679.7M +3.47% | |
Operating Profit | 194.4M +75.98% | 110.5M +107.19% | 53.3M -25.79% | 71.8M -9.04% | |
Interest Income | 2.0M -24.22% | 2.6M -41.39% | 4.5M +33.35% | 3.4M +311.15% | |
Interest Expense | -44.4M +28.40% | -34.6M +86.67% | -18.5M +20.98% | -15.3M +29.02% | |
Interest Income and Expense and Net | -42.4M +32.71% | -32.0M +127.42% | -14.1M +17.52% | -12.0M +8.20% | |
Total Nonoperating Income and Expense | -44.4M +28.40% | -34.6M +86.67% | -18.5M +20.98% | -15.3M +29.02% | |
Income before Taxes | 137.3M +102.00% | 68.0M +522.87% | 10.9M -79.81% | 54.1M -25.24% | |
Income Taxes | 37.6M +90.71% | 19.7M +132.11% | 8.5M -60.40% | 21.5M -7.29% | |
Extraordinary Items | 5.3M 0.00% | 5.3M N/A | N/A N/A | N/A N/A | |
Net Income | 99.7M +106.61% | 48.3M +1,897.68% | 2.4M -92.59% | 32.6M -33.69% | |
Net Income from Continuing Operations Applicable to Common | 137.3M +102.00% | 68.0M +522.87% | 10.9M -79.81% | 54.1M -25.24% | |
Basic EPS and Net Income | 2.46 +106.72% | 1.19 +1,883.33% | 0.06 -92.59% | 0.81 -33.06% | |
Diluted EPS and Net Income | 2.43 +104.20% | 1.19 +1,883.33% | 0.06 -92.59% | 0.81 -33.06% | |
Basic Weighted Average Shares | 40.5M +0.08% | 40.5M +0.03% | 40.5M 0.00% | 40.5M 0.00% | |
Diluted Weighted Average Shares | 41.0M +0.70% | 40.7M +0.38% | 40.5M +0.05% | 40.5M 0.00% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 61.4M -9.73% | 68.0M -3.65% | 70.6M +71.05% | 41.3M -44.40% | |
Short-Term Investments | 20.6M +128.61% | 9.0M -79.55% | 44.0M +10.00% | 40.0M +135.29% | |
Cash and Cash Equivalents and Short-Term Investments | 82.0M +6.43% | 77.0M -32.78% | 114.6M +41.01% | 81.3M -10.92% | |
Total Current Assets | 935.5M +15.41% | 810.6M +34.88% | 601.0M +2.61% | 585.7M +3.44% | |
Accumulated Depreciation | 315.4M +13.05% | 279.0M +13.70% | 245.4M -6.93% | 263.6M +9.40% | |
Property and Plant and Equipment and Net | 369.2M +4.08% | 354.7M +74.47% | 203.3M +3.95% | 195.6M +18.18% | |
Total Long-Term Assets | 106.5M +7.01% | 99.5M +27.07% | 78.3M -4.34% | 81.8M -1.26% | |
Total Assets | 1.5B +10.31% | 1.4B +38.56% | 982.2M +1.11% | 971.4M +4.26% | |
Income Taxes Payable | 26.1M +107.21% | 12.6M +250.03% | 3.6M -65.33% | 10.4M +26.30% | |
Total Short-Term Debt | 25.0M +54.00% | 16.3M -45.46% | 29.8M +33.64% | 22.3M +48.63% | |
Total Current Liabilities | 316.5M +7.84% | 293.5M +43.76% | 204.1M +15.99% | 176.0M -7.77% | |
Total Long-Term Debt | 707.8M +0.76% | 702.4M +53.27% | 458.3M +1.27% | 452.5M +8.28% | |
Total Long-Term Liabilities | 91.5M +15.40% | 79.3M +25.68% | 63.1M +4.57% | 60.3M -0.25% | |
Total Liabilities | 1.1B +3.77% | 1.1B +48.19% | 725.5M +5.32% | 688.9M +2.93% | |
Retained Earnings | 353.0M +29.43% | 272.7M +11.81% | 243.9M -6.53% | 260.9M +5.31% | |
Total Stockholders Equity | 385.5M +34.93% | 285.7M +11.32% | 256.6M -9.16% | 282.5M +7.65% | |
Total Shares Outstanding | 21.1M +3.44% | 20.4M -49.71% | 40.5M 0.00% | 40.5M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | 69.0M -13.94% | 80.1M -8.53% | 87.6M +558.11% | 13.3M -57.94% | |
Capital Expenditures | 59.1M +54.30% | 38.3M -7.14% | 41.2M -20.38% | 51.8M +39.82% | |
Cash from Investing Activities | -71.5M -75.25% | -288.7M +499.01% | -48.2M -34.89% | -74.0M +227.77% | |
Dividends Paid | 19.5M +0.07% | 19.4M +0.04% | 19.4M 0.00% | 19.4M 0.00% | |
Cash from Financing Activities | -6.6M -103.17% | 207.1M +3,160.49% | -6.8M -125.08% | 27.0M +65.13% | |
Financials Ratio | |||||
Gross Margin | 33.76% +9.42% | 30.85% +0.29% | 30.77% +0.88% | 30.50% +0.69% | |
Operating Margin | 12.81% +50.26% | 8.52% +62.67% | 5.24% -28.70% | 7.35% -12.35% | |
Return on Assets | 6.97% +69.14% | 4.12% +1,565.87% | 0.25% -92.78% | 3.43% -38.23% | |
Return on Equity | 29.72% +66.95% | 17.80% +1,886.05% | 0.90% -92.51% | 11.97% -39.05% | |
Revenue Growth | 17.12% -37.46% | 27.37% +572.64% | 4.07% +7.61% | 3.78% -71.07% | |
Current Ratio | 2.96 +7.02% | 2.76 -6.18% | 2.94 -11.54% | 3.33 +12.16% | |
Cash Ratio | 0.19 -16.26% | 0.23 -32.99% | 0.35 +47.44% | 0.23 -39.71% | |
Debt-to-Equity Ratio | 1.90 -24.43% | 2.52 +32.28% | 1.90 +13.15% | 1.68 +1.89% | |
Debt-to-Assets Ratio | 0.49 -7.57% | 0.53 +6.28% | 0.50 +1.66% | 0.49 +5.19% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow